Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$35.61 - $76.23 $104,088 - $222,820
-2,923 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$57.56 - $82.54 $287 - $412
5 Added 0.17%
2,923 $204,000
Q4 2021

Jan 14, 2022

BUY
$72.5 - $100.68 $20,155 - $27,989
278 Added 10.53%
2,918 $227,000
Q3 2021

Oct 19, 2021

BUY
$90.24 - $124.05 $41,329 - $56,814
458 Added 20.99%
2,640 $252,000
Q2 2021

Jul 19, 2021

SELL
$93.66 - $139.27 $29,502 - $43,870
-315 Reduced 12.62%
2,182 $271,000
Q1 2021

Apr 27, 2021

BUY
$116.57 - $155.01 $291,075 - $387,059
2,497 New
2,497 $329,000
Q4 2018

Feb 08, 2019

SELL
$56.04 - $82.66 $5,604 - $8,266
-100 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$48.29 - $80.6 $4,829 - $8,059
100 New
100 $8,000
Q2 2018

Aug 13, 2018

SELL
$37.84 - $69.96 $15,627 - $28,893
-413 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$46.49 - $60.51 $19,200 - $24,990
413
413 $22,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.